Oramed Pharmaceuticals Inc

Market Cap

$159M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.71+$1.00 (+36.76%)

Jun 5, 2026

52W High $4.7352W Low $1.92

Company Details

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III ...

CEO

—

IPO Date

Apr 21, 2006

Website

oramed.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

$110M

EPS (Diluted)

Free Cash Flow

-$9M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

1.4x

Earnings Reports

Q2 2026

Aug 14, 2026

PENDING

Q1 2026

May 19, 2026

$0-100.0%

FY 2025

Mar 26, 2026

$2M

Q4 2025

Mar 26, 2026

Q3 2025

Nov 13, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding